Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1

Journal of Investigative Dermatology

Volumn 134, Issue 2, 2014, Pages 441-451

  Bell, Rachel E ^a   Khaled, Mehdi ^b,c,d   Netanely, Dvir ^a   Schubert, Steffen ^c,e   Golan, Tamar ^a   Buxbaum, Amir ^a   Janas, Maja M ^c,f   Postolsky, Benny ^a   Goldberg, Michael S ^c   Shamir, Ron ^a   Levy, Carmit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Cenix BioScience GmbH   (Germany)

^f NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICRORNA; MICRORNA 211; NUAK1 PROTEIN; SMALL UNTRANSLATED RNA; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; MELANOMA CELL; METASTATIC MELANOMA; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; TUMOR INVASION;

BINDING SITES; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; PROTEIN KINASES; REPRESSOR PROTEINS; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTOME; TUMOR CELLS, CULTURED;

EID: 84892780770     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.340     Document Type: Article

References (66)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 100:3983-8
2. Alexaki V-I, Javelaud D, Van Kempen LCL et al. (2010) GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst 102:1148-59
3. Alon U (2006) An Introduction to Systems Biology: Design Principles of Biological Circuits, vol. 10. Chapman & Hall/CRC
4. Ashburner M, Ball CA, Blake JA et al. (2000) Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-9
5. Bartel DP (2009) MicroRNAs: Target recognition and regulatory functions. Cell 136:215-33
6. Bell RE, Levy C (2011) The three M's: Melanoma, microphthalmia-Associated transcription factor and microRNA. Pigment Cell Melanoma Res 24:1088-106
7. Boyle GM, Woods SL, Bonazzi VF et al. (2011) Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res 24:525-37
8. Carreira S, Goodall J, Denat L et al. (2006) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20:3426-39
9. Chan E, Patel R, Nallur S et al. (2011) MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 10:1845-52
10. Chang X-Z, Yu J, Liu H-Y et al. (2012) ARK5 is associated with the invasive and metastatic potential of human breast cancer cells. J Cancer Res Clin Oncol 138:247-54
11. Cheli Y, Giuliano S, Fenouille N et al. (2011) Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 31:2461-70
12. Clark K, Plater L, Peggie M et al. (2009) Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkB kinase E A distinct upstream kinase mediates SER-172 phosphorylation and activation. J Biol Chem 284:14136-46
13. Clarke MF, Dick JE, Dirks PB et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-44
14. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-14
15. Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: Models and concepts. Annu Rev Med 58:267-84
16. Eichhoff OM, Weeraratna A, Zipser MC et al. (2011) Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. Pigment Cell Melanoma Res 24:631-42
17. Eisen MB, Spellman PT, Brown PO et al. (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci 95:14863-8
18. Feige E, Yokoyama S, Levy C et al. (2011) Hypoxia-induced transcriptional repression of the melanoma-Associated oncogene MITF. Proc Natl Acad Sci 108:E924-33
19. Feldman RI, Wu JM, Polokoff MA et al. (2005) Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1. J Biol Chem 280:19867-74
20. Fidler IJ (2003) The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-8
21. Friedman RC, KK-H Farh, Burge CB et al. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105
22. Garraway LA, Weir BA, Zhao X et al. (2005) 'Lineage addiction' in human cancer: Lessons from integrated genomics. Cold Spring Harbor Symp Quant Biol 70:25-34
23. Garraway LA, Widlund HR, Rubin MA et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436:117-22
24. Gupta PB, Fillmore Christine M, Jiang G et al. (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146:633-44
25. Gupta PB, Kuperwasser C, Brunet J-P et al. (2005) The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 37:1047-54
26. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144:646-74
27. Hoek KS, Eichhoff OM, Schlegel NC et al. (2008) in vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68:650-6
28. Hoek KS, Goding CR (2010) Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res 23:746-59
29. Hoek KS, Schlegel NC, Eichhoff OM et al. (2008) Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 21:665-76
30. Hou X, Liu JE, Liu W et al. (2011) A new role of NUAK1: Directly phosphorylating p53 and regulating cell proliferation. Oncogene 30:2933-42
31. Huang JC, Babak T, Corson TW et al. (2007) Using expression profiling data to identify human microRNA targets. Nat Meth 4:1045-9
32. Humbert N, Navaratnam N, Augert A et al. (2010) Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J 29: 376-86
33. Inui M, Martello G, Piccolo S (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11:252-63
34. Javelaud D, Alexaki VI, Pierrat MJ et al. (2011) GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Pigment Cell Melanoma Res 24: 932-43
35. Kanemaru H, Fukushima S, Yamashita J et al. (2011) The circulating micro-RNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 61:187-93
36. Kasinski AL, Slack FJ (2011) MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11:849-64
37. Krutzfeldt J, Rajewsky N, Braich R et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-9
38. Kusakai G, Suzuki A, Ogura T et al. (2004) ARK5 expression in colorectal cancer and its implications for tumor progression. Am J Pathol 164:987-95
39. Leidinger P, Keller A, Borries A et al. (2010) High-Throughput miRNA profiling of human melanoma blood samples. BMC Cancer 10:262
40. Levy C, Khaled M, Fisher DE (2006) MITF: Master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12:406-14
41. Levy C, Khaled M, Iliopoulos D et al. (2010) Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 40:841-9
42. Lin WM, Baker AC, Beroukhim R et al. (2008) Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 68:664-73
43. Lu J, Getz G, Miska EA et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435:834-8
44. Mazar J, DeYoung K, Khaitan D et al. (2010) The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PloS One 5:e13779
45. Mendell Joshua T, Olson Eric N (2012) MicroRNAs in stress signaling and human disease. Cell 148:1172-87
46. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23-8
47. Nunez-Iglesias J, Liu C-C, Morgan TE et al. (2010) Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PloS One 5:e8898
48. Pinner S, Jordan P, Sharrock K et al. (2009) Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res 69:7969-77
49. Quintana E, Shackleton M, Foster HR et al. (2010) Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18:510-23
50. Rosenfeld N, Aharonov R, Meiri E et al. (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26:462-9
51. Scheel C, Weinberg RA (2011) Phenotypic plasticity and epithelialmesenchymal transitions in cancer-And normal stem cells? Int J Cancer 129:2310-4
52. Shah M, Bhoumik A, Goel V et al. (2010) A role for ATF2 in regulating MITF and melanoma development. PLoS Genet 6:e1001258
53. Shalgi R, Lieber D, Oren M et al. (2007) Global and local architecture of the mammalian microRNA-Transcription factor regulatory network. PLoS Comput Biol 3:e131
54. Shaw RJ, Kosmatka M, Bardeesy N et al. (2004) The tumor suppressor LKB1
55. kinase directly activates AMP-Activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 101:3329-35
56. Smith AP, Hoek K, Becker D (2005) Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol Ther 4:1018-29
57. Strub T, Giuliano S, Ye T et al. (2011) Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30:2319-32
58. Suzuki A, Iida S, Kato-Uranishi M et al. (2005) ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma. Oncogene 24:6936-44
59. Suzuki A, Kusakai G-i, Kishimoto A et al. (2003) Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J Biol Chem 278:48-53
60. Suzuki A, Lu J, Kusakai G et al. (2004) ARK5 is a tumor invasion-Associated factor downstream of Akt signaling. Mol Cell Biol 24:3526-35
61. Thurber AE, Douglas G, Sturm EC et al. (2011) Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene 30:3036-48
62. Widmer DS, Cheng PF, Eichhoff OM et al. (2012) Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res 25:343-53
63. Zagorska A, Deak M, Campbell DG et al. (2010) New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci Signal 3:ra25
64. Zbytek B, Peacock DL, Seagroves TN et al. (2012) Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermato-Endocrinology 4:1-13
65. Zhang L, Huang J, Yang N et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-41
66. Zheng B, Jeong JH, Asara JM et al. (2009) Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol Cell 33:237-47